📈 நேரலை சந்தை கண்காணிப்பு

NSE மற்றும் BSE-யின் ஒவ்வொரு கார்ப்பரேட் அறிவிப்பும், AI-யால் சில நிமிடங்களில் படிக்கப்பட்டு விளக்கப்படுகிறது — தாக்கம், முக்கிய புள்ளிவிவரங்கள், குறுகிய/நீண்டகாலப் பார்வை, கவனிக்க வேண்டியவை.

நேரலை இன்று 333 பகுப்பாய்வு செய்யப்பட்டது
பின்தொடர்Telegram
333
இன்று
169,034
இதுவரை பகுப்பாய்வு செய்யப்பட்டவை
49,996
நேர்மறை
8,544
எதிர்மறை
100,683
நடுநிலை
9,743
கண்காணி
குறிப்பு: இவை NSE பொது அறிக்கைகளின் AI-உருவாக்கிய, கல்வி நோக்கச் சுருக்கங்கள் — ஒவ்வொரு ஆவணத்தையும் ஆதாரமாகக் கொண்டவை, ஆனால் முதலீட்டு ஆலோசனை அல்ல, மேலும் முழுமையற்றதாகவும் இருக்கலாம். அசல் அறிக்கையுடன் சரிபார்க்கவும், செயல்படுவதற்கு முன் SEBI-பதிவு பெற்ற முதலீட்டு ஆலோசகரை அணுகவும்.
அழி
1,000+ அறிவிப்புகள் பொருந்தும் தாக்கம் 5+ Symbol: IL
நடுநிலை தாக்கம் 5/10 நிதி முடிவுகள்

Synergy Green targets ₹600-650 Cr revenue from existing 45K MT capacity; H1 income up 20% to ₹192 Cr

Synergy Green Industries reported its Q2 and H1 FY27 earnings transcript, revealing H1 total income rose 20.2% YoY to ₹192 Cr from ₹159.76 Cr. Operating margins faced compression, with H1 PBDIT margin declining to 8.9% (₹17.13 Cr) versus 15.6% in H1 FY26 due to input cost escalations. Foundry capacity utilization stood at 75% in H1 and is projected to reach an average of 80% for the full year. Management revised its peak revenue potential from current 45,000 MT capacity upwards to ₹600-650 Cr (up from ₹550-600 Cr) driven by inflation and pricing adjustments.

நேர்மறை தாக்கம் 7/10 நிதி முடிவுகள்

SAILIFE Reports Q2 FY27 Revenue Up 23% YoY to ₹659 Cr, Capex Plan at ₹1,100-1,300 Cr

Sai Life Sciences released its Q2 and H1 FY27 investor presentation, reporting consolidated quarterly revenue growth of 23% YoY to ₹659 crore. EBITDA for Q2 FY27 stood at ₹187 crore (up 20% YoY) with an EBITDA margin of 28%, while PAT increased 17% YoY to ₹98 crore. For H1 FY27, revenue reached ₹1,213 crore and PAT rose 19% to ₹172 crore. The company incurred ₹621 crore in capex during H1 FY27 (representing ~28% of TTM revenue) and remains on track for an annual capex target of ₹1,100 to ₹1,300 crore.

நேர்மறை தாக்கம் 7/10 விரிவாக்கம்

GAIL Subsidiary Commissions 1.25 MTPA PTA Plant at Mangalore

GAIL Mangalore Petrochemicals Limited (GMPL), a wholly owned subsidiary of GAIL (India) Limited, has successfully commissioned its 1.25 million tons per annum (MTPA) Purified Terephthalic Acid (PTA) plant at MSEZ, Mangalore. The facility, originally acquired in 2023 under CIRP as JBF Petrochemicals Limited, underwent extensive revival and refurbishment. The company will market the PTA output under the brand name 'G-Tex'. This marks a major step in GAIL's planned petrochemical expansion, targeting downstream polyester, textile, and packaging markets.

நேர்மறை தாக்கம் 7/10 விரிவாக்கம்

Texmaco Rail Secures Domestic Wagon Orders Worth ₹428.55 Cr

Texmaco Rail & Engineering Limited has secured three domestic orders totaling ₹428.55 crore (including taxes) for the manufacture and supply of specialized wagons. The largest contract of ₹329.53 crore was awarded by Jujhar Logistics & Travels for 15 rakes, followed by APL Logistics Vascor Automotive (₹68.04 crore for 3 rakes) and Ultratech Cement (₹30.98 crore for 1 rake). The total order value represents approximately 10.1% of the company's TTM revenue of ₹4,223 crore, reinforcing its diversification into private sector freight logistics. Execution schedules extend through February 2027 to December 2027.

எதிர்மறை தாக்கம் 6/10 நிதி முடிவுகள்

Basilic Fly Studio Releases Q2/H1 FY27 Presentation: Consolidated H1 PAT Falls 47.5% YoY to ₹13.9 Cr

Basilic Fly Studio shared its Q2 and H1 FY27 earnings investor presentation. Consolidated H1 FY27 revenue rose 11.4% YoY to INR 210.9 Cr (INR 2,109 Mn), but operational EBITDA declined 15.7% YoY to INR 37.0 Cr, resulting in an EBITDA margin compression to 17.54%. Consolidated net profit for H1 dropped 47.5% YoY to INR 13.9 Cr (PAT margin of 6.55%). In Q2 FY27, consolidated revenue stood at INR 107.4 Cr (+12.8% YoY) with PAT declining 49.7% YoY to INR 7.3 Cr, reflecting margin pressure following the integration of international operations.

📊 கடந்த 7 நாட்கள் — உணர்வு அடிப்படையில் பகுப்பாய்வு செய்யப்பட்ட அறிவிப்புகள்

நேர்மறைஎதிர்மறைநடுநிலைகவனம்
எதிர்மறை தாக்கம் 7/10 நிதி முடிவுகள்

Basilic Fly Studio Q2 Net Profit Drops 49.7% YoY to ₹7.3 Cr Despite 12.8% Revenue Growth

Basilic Fly Studio reported a 12.82% YoY increase in consolidated revenue to INR 107.4 Cr for Q2 FY27, while H1 FY27 revenue rose 11.35% YoY to INR 210.9 Cr. However, operating and bottom-line profitability experienced significant contraction; Q2 EBITDA fell 11.07% to INR 22.5 Cr with margins declining to 20.95%, and net profit dropped 49.66% YoY to INR 7.3 Cr. The company cited a higher revenue share from its London subsidiary (One Of Us) and an increase in depreciation & amortization expenses for the profit squeeze. To improve long-term margins, the company is opening a Bengaluru studio in January 2027 and implementing hybrid cloud infrastructure that cuts cloud expenses by 50%.

நேர்மறை தாக்கம் 7/10 நிதி முடிவுகள்

Q2 FY27 Consolidated Revenue Up 37% YoY to ₹1,801.5 Cr; Declares ₹5 Interim Dividend

Pearl Global Industries reported Q2 FY27 consolidated net segment revenue of ₹1,801.53 Cr, up 37.2% YoY from ₹1,312.93 Cr in Q2 FY26. Consolidated profit before tax rose 69.8% YoY to ₹134.77 Cr compared to ₹79.37 Cr in the corresponding quarter last year. The Board declared a 1st interim dividend of ₹5 per equity share (100% on face value of ₹5), with the record date set for November 13, 2026. Growth was led by strong geographical expansion, with UAE revenue jumping sharply to ₹539.60 Cr during the quarter.

நடுநிலை தாக்கம் 5/10 நிதி முடிவுகள்

BAG Films Approves Q2 FY27 Results; Subsidiaries Clock Rs 62.9 Cr H1 Revenue

B.A.G. Films and Media Limited approved its standalone and consolidated unaudited financial results for the quarter and half-year ended September 30, 2026. The consolidated figures incorporate subsidiaries including E24 Glamour, News24 Broadcast India, and Skyline Radio Network, which collectively contributed Rs 6,288.28 Lakh (Rs 62.88 Cr) in total income for H1 FY27. Subsidiaries also recorded total assets of Rs 38,831.45 Lakh and a profit before tax of Rs 121.82 Lakh during the six-month period. The statutory auditors issued an unmodified Limited Review Report for both standalone and consolidated statements.

நேர்மறை தாக்கம் 8/10 நிதி முடிவுகள்

Q2 FY27 Adjusted PAT Jumps 249% YoY to ₹56 Cr; Revenue Up 31% to ₹446 Cr

GHCL Textiles reported strong standalone results for Q2 FY27, with total revenue rising 31% YoY to ₹446 crore and EBITDA surging 141% YoY to ₹92 crore. Adjusted net profit increased 249% YoY to ₹56 crore, after adjusting for an exceptional loss of ₹27 crore (₹20 crore net of tax) due to a fire at its Tuticorin godown. For H1 FY27, revenue reached ₹856 crore (up 40% YoY) and adjusted PAT stood at ₹95 crore (up 223% YoY). The company's fabric revenue share expanded to 16.4% from 11.4% in Q2 FY26, supporting higher margin realization.

நேர்மறை தாக்கம் 8/10 நிதி முடிவுகள்

Q2 PAT surges 74.7% to ₹126 Cr; ₹675-725 Cr capex plan announced for FY27-FY30

Pearl Global Industries reported its highest-ever quarterly consolidated revenue of ₹1,802 crore for Q2FY27, up 37.2% YoY, with PAT jumping 74.7% YoY to ₹126 crore. For H1FY27, revenue reached ₹3,330 crore (+31.1% YoY) and PAT reached ₹225 crore (+63.6% YoY), driven by shipment volume growing to 43.6 million pieces. The company inaugurated a new Bangladesh facility adding ~7 million pieces annually, taking total capacity to ~108 million pieces. Additionally, management announced a capex plan of ₹675-725 crore between FY27 and FY30 aiming for ₹9,000-10,000 crore revenue by FY30, and declared an interim dividend of ₹5.0 per share.

நேர்மறை தாக்கம் 7/10 நிதி முடிவுகள்

Patil Automation H1 FY27 Net Profit Rises 38% YoY to ₹10.40 Cr, Revenue Up 41% to ₹104.01 Cr

Patil Automation Limited reported standalone revenue from operations of ₹101.22 crore (Total Income of ₹104.01 crore) for the half-year ended September 30, 2026, up 41.4% YoY compared to ₹73.55 crore in H1 FY26. Standalone Profit After Tax grew 38.2% YoY to ₹10.40 crore from ₹7.53 crore in H1 FY26, with half-year basic EPS coming in at ₹4.77. The company also disclosed a preferential allotment on October 23, 2026, of 20,76,600 equity shares and 18,24,000 warrants at ₹246 per unit, whose listing is currently underway.

நேர்மறை தாக்கம் 8/10 நிதி முடிவுகள்

KPIL Q2 FY27 PAT Rises 23% YoY to ₹292 Cr; Net Debt Drops 98% to ₹72 Cr

Kalpataru Projects International Limited (KPIL) reported strong Q2 FY27 financial results, with consolidated revenue rising 7% YoY to ₹7,004 crore and PAT growing 23% YoY to ₹292 crore. The company achieved a near net-debt-free status with net debt plunging over 98% YoY to ₹72 crore from ₹3,169 crore, while working capital days improved to 68 days. Order inflows for YTD FY27 surged 60% YoY to ₹23,934 crore, lifting the total order book to an all-time high of ₹71,846 crore (approx. 2.6x TTM revenue). Additionally, CRISIL and India Ratings upgraded the company's credit rating to AA+/Stable, while Swedish subsidiary Linjemontage was listed on Nasdaq Stockholm with a market cap of ~₹2,300 crore.

நேர்மறை தாக்கம் 7/10 நிதி முடிவுகள்

KPIL Q2 FY27: Cons PAT Up 40% to ₹300 Cr; Order Book Reaches ₹71,846 Cr

Kalpataru Projects International Limited reported strong Q2 FY27 performance, with consolidated revenue (ex-road SPVs & Brazil subsidiary) up 13% YoY to ₹6,995 crore and PAT expanding 40% YoY to ₹300 crore. The total order book reached a record ₹71,846 crore as of September 30, 2026, representing 2.6x of TTM revenue (₹27,380 crore). Net debt reduced sharply to near-zero levels at ₹72 crore, supported by robust cash flows and working capital discipline (68 days). Additionally, the company highlighted value unlocking from the listing of its Swedish subsidiary Linjemontage at ~₹2,300 crore valuation.

நேர்மறை தாக்கம் 7/10 நிர்வாகம்

KPIL Appoints Amit Uplenchwar as Joint MD & CEO for 5-Year Term From Jan 2027

Kalpataru Projects International Limited (KPIL) has approved the elevation and appointment of Mr. Amit Uplenchwar as Joint Managing Director & CEO (designate), effective January 1, 2027, for a 5-year tenure ending December 31, 2031, subject to shareholder approval. Mr. Uplenchwar has been with KPIL for over 6 years and has led major international expansions, including marquee project wins with Saudi Aramco and UAE gas pipeline projects. Additionally, the board approved promoter reclassification requests from Mr. Imtiaz Kanga and Mrs. Yasmin Imtiaz Kanga to the 'Public' category under Regulation 31A. The leadership transition ensures strategic continuity as KPIL executes its massive order book of over ₹65,475 crore.

நடுநிலை தாக்கம் 5/10 நிதி முடிவுகள்

KPIL Approves Q2 FY27 Financial Results; Reports Nil Deviation in Debt Proceeds

Kalpataru Projects International Limited reported its unaudited standalone and consolidated financial results for the quarter and half-year ended September 30, 2026. The statutory auditors issued an unmodified limited review report, covering multiple subsidiaries and joint operations. Additionally, the company submitted a statement under SEBI regulations confirming nil deviation or variation in the utilization of proceeds from listed Non-Convertible Debt securities. The board meeting concluded at 06:13 p.m. IST on November 05, 2026.

எதிர்மறை தாக்கம் 6/10 நிதி முடிவுகள்

Vilas Transcore H1 FY27 Net Profit Drops 29% YoY to ₹17.24 Cr Despite 6% Revenue Growth

Vilas Transcore reported its standalone financial results for the half year ended September 30, 2026. Revenue from operations grew 6.0% YoY to ₹242.48 crore compared to ₹228.76 crore in H1 FY26. However, net profit fell 29.3% YoY to ₹17.24 crore from ₹24.38 crore, impacted by higher raw material costs and increased depreciation and finance charges. The company also confirmed it has utilized ₹94.46 crore of its ₹95.26 crore IPO proceeds, leaving ₹79.84 lakhs unutilized.

நேர்மறை தாக்கம் 5/10 நிதி முடிவுகள்

Classic Electrodes H1 FY27 Net Profit Rises 12.1% YoY to ₹7.28 Cr; Revenue Up 17.9%

Classic Electrodes (India) Limited reported its standalone unaudited financial results for the half year ended September 30, 2026. Revenue from operations increased by 17.86% YoY to ₹14,397.24 lakhs compared to ₹12,215.74 lakhs in the corresponding previous half year. Profit after tax rose 12.15% YoY to ₹727.54 lakhs from ₹648.74 lakhs. The company also confirmed 100% utilization of its ₹4,150.93 lakhs IPO proceeds as of September 30, 2026.

நடுநிலை தாக்கம் 5/10 நிதி முடிவுகள்

Vilas Transcore H1 FY27 Revenue Up 6% to ₹242.5 Cr; Guides 30-35% FY27 Growth

Vilas Transcore reported standalone H1 FY27 revenue of ₹242.5 crore, up 6.0% YoY, driven by a 28.1% volume growth in CRGO laminations to 11,697 MT despite lower steel realizations. Net profit dropped 29.3% YoY to ₹17.2 crore due to lower realizations, higher depreciation, and ramp-up costs, though it recovered 13.5% sequentially over H2 FY26. The company commenced commercial sales of copper and aluminium conductors in September 2026 and secured POWERGRID approval up to 220 kV at Unit III. Management guided for 30% to 35% growth in both volume and revenue for FY27 while expecting to maintain margins.

நடுநிலை தாக்கம் 5/10 நிதி முடிவுகள்

Pidilite Q2 Standalone Revenue Up 21.7%, EBITDA Margin Softens to 20.4% on VAM Cost Spike

Pidilite Industries released its Q2 FY27 earnings call transcript highlighting a standalone revenue growth of 21.7% year-on-year, driven by underlying volume growth (UVG) of 10.7%. However, gross margins contracted by 720 bps due to elevated raw material prices, as VAM consumption costs jumped to $1,630/tonne compared to $1,370 in Q1. Consequently, standalone EBITDA margins declined 430 bps to 20.4%, buffered partly by operational leverage. Across H1, the company maintained healthy momentum with standalone revenues up 22% and an EBITDA margin of 23.5%.

நேர்மறை தாக்கம் 5/10 சட்டம்

NCLAT Sets Aside CIRP on Shilpa Medicare's Subsidiary FTF Pharma, Annuls Insolvency

The Hon'ble NCLAT vide order dated 04 November 2026 has set aside the NCLT Ahmedabad order dated 09 September 2026, which had initiated a Corporate Insolvency Resolution Process (CIRP) against Shilpa Medicare's wholly owned subsidiary, FTF Pharma Private Limited. The operational debt claim initiated by Immacule Lifesciences under Section 9 of the IBC has been dismissed as parties settled their disputes. The management control of FTF Pharma has been restored to its Board of Directors with immediate effect, removing insolvency overhang. Shilpa Medicare confirmed that with the annulment of the insolvency order, there is no adverse operational or financial impact on the listed entity.

⚠️ இந்தத் தளம் எவ்வாறு உருவாக்கப்படுகிறது: சந்தைத் தரவுப் பக்கங்கள் NSE/BSE வெளியீடுகள் மற்றும் நிறுவனங்களின் தாக்கல்களிலிருந்து தானாகக் கணக்கிடப்படுகின்றன; செய்திக் கட்டுரைகளும் அறிவிப்புப் பகுப்பாய்வுகளும் AI உதவியுடன் எழுதப்படுகின்றன, மனித மேற்பார்வையுடன்: AI உருவாக்குவதை எங்கள் ஆசிரியர்கள் மதிப்பாய்வு செய்கின்றனர். இரண்டிலும் பிழைகள் இருக்கலாம். எந்தவொரு முதலீட்டு முடிவுக்கு முன்பும் அசல் மூலங்களில் சரிபார்க்கவும். முதலீட்டு ஆலோசனை அல்ல; Flash Finance SEBI-பதிவு பெற்றது அல்ல. நாங்கள் AI-ஐ எவ்வாறு பயன்படுத்துகிறோம்